Mutations Y493G and K546D in human HSP90 disrupt binding of celastrol and reduce interaction with Cdc37
Open Access
- 7 May 2016
- journal article
- research article
- Published by Wiley in FEBS Open Bio
- Vol. 6 (7) , 729-734
Abstract
Celastrol, a natural compound derived from the Chinese herb Tripterygium wilfordii Hook F, has been proven to inhibit heat shock protein 90 (HSP90) activity and has attracted much attention because of its promising effects in cancer treatment and in ameliorating degenerative neuron diseases. However, the HSP90 structure involved in celastrol interaction is not known. Here, we report a novel celastrol‐binding pocket in the HSP90 dimer, predicted by molecular docking. Mutation of the two key binding pocket amino acids (Lys546 and Tyr493) disrupted the binding of celastrol to HSP90 dimers, as detected by isothermal titration calorimetry (ITC). Interestingly, such mutations also reduced binding between HSP90 and the cochaperone Cdc37, thus providing a new explanation for reported findings that celastrol shows more obvious effects in disrupting binding between HSP90 and Cdc37 than between HSP90 and other cochaperones. In short, our work discloses a novel binding pocket in HSP90 dimer for celastrol and provides an explanation as to why celastrol has a strong effect on HSP90 and Cdc37 binding.Keywords
Funding Information
- National Natural Science Foundation of China (81102349)
This publication has 15 references indexed in Scilit:
- Celastrol Stimulates Hypoxia-Inducible Factor-1 Activity in Tumor Cells by Initiating the ROS/Akt/p70S6K Signaling Pathway and Enhancing Hypoxia-Inducible Factor-1α Protein SynthesisPLOS ONE, 2014
- Celastrol targets proteostasis and acts synergistically with a heat-shock protein 90 inhibitor to kill human glioblastoma cellsCell Death & Disease, 2014
- Celastrol Induces Apoptosis in Gefitinib-Resistant Non-Small Cell Lung Cancer Cells via Caspases-Dependent Pathways and Hsp90 Client Protein DegradationMolecules, 2014
- Phenotypic Identification of the Redox Dye Methylene Blue as an Antagonist of Heat Shock Response Gene Expression in Metastatic Melanoma CellsInternational Journal of Molecular Sciences, 2013
- HSP90 inhibitor, celastrol, arrests human monocytic leukemia cell U937 at G0/G1 in thiol-containing agents reversible wayMolecular Cancer, 2010
- Characterization of Celastrol to Inhibit Hsp90 and Cdc37 InteractionJournal of Biological Chemistry, 2009
- Molecular Mechanism of Inhibition of the Human Protein Complex Hsp90–Cdc37, a Kinome Chaperone–Cochaperone, by Triterpene CelastrolAngewandte Chemie International Edition, 2009
- A novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cellsMolecular Cancer Therapeutics, 2008
- Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulatorsCancer Cell, 2006
- Celastrols as Inducers of the Heat Shock Response and CytoprotectionJournal of Biological Chemistry, 2004